NCT02778906 Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia Status COMPLETED Phase PHASE3
NCT02598466 Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa Status COMPLETED Phase N/A
NCT02592798 Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD) Status COMPLETED Phase PHASE2
NCT02557100 Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT02547493 Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients Status COMPLETED Phase NA
NCT02504268 Effects of Abatacept in Patients With Early Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT02353780 Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept Status TERMINATED Phase PHASE4
NCT02281058 Open-label Pilot Study of Abatacept for the Treatment of Vitiligo Status UNKNOWN Phase PHASE1
NCT02270957 Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches Status COMPLETED Phase PHASE2
NCT02232880 Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation Status TERMINATED Phase PHASE2
NCT02169544 Post-marketing Study Assessing the Long-Term Safety of Abatacept Status COMPLETED Phase N/A
NCT02161406 A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis Status COMPLETED Phase PHASE2
NCT02109666 Long Term Experience With Abatacept in Routine Clinical Practice Status COMPLETED Phase N/A
NCT02108860 Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) Status COMPLETED Phase PHASE3
NCT02078882 Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis Status COMPLETED Phase PHASE4
NCT02053727 Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background Status WITHDRAWN Phase NA
NCT02037737 Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting Status COMPLETED Phase N/A
NCT02027298 Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study Status WITHDRAWN Phase PHASE2